Home » Topics » BioWorld Science

BioWorld Science
RSS

KRP-A218, an oral PI4KB inhibitor, is a potent antiviral in vivo

Oct. 5, 2021

Protein mimetic amyloid inhibitor shows antitumor activity in vivo

Oct. 5, 2021

Targeting ADGRF1 for obesity and associated metabolic diseases

Oct. 5, 2021

OncoTherapy Science presents data on OTSA-101 in cervical cancer mouse model

Oct. 5, 2021

Selecta and Takeda enter strategic licensing agreement for lysosomal storage disorders

Oct. 5, 2021

JSF-3151 demonstrates efficacy in mouse model of MRSA infection

Oct. 5, 2021

Microbiome therapy SER-155 may restore colonization resistance and prevent infection

Oct. 5, 2021

Fochon Pharmaceuticals synthesizes new BTK inhibitors

Oct. 5, 2021

Janpix divulges new STAT5 inhibitors

Oct. 5, 2021

University of Kentucky identifies histone demethylase and Wnt signaling inhibitors

Oct. 5, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...